Admissions open for Ph.D. in Agricultural, Food, and Biomanufacturing fields at NABI, with degree awarded by RCB.

In 2025 alone, the agency issued over 50 oncology approvals([1]) , but the real story is the aggressive pivot toward targeted therapies for high-unmet-need solid tumors. That momentum has accelerated ...

Equity-Insider.com News Commentary – The market is waking up to a $71 billion reality[1]. We are seeing a decisive move away ...

A renewed focus on research and experiential learning has driven enrollment in the undergraduate, master's and PhD programs ...

Issued on behalf of Oncolytics Biotech Inc.VANCOUVER, BC, Feb. 5, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – The FDA isn't just approving ...

Welcome to Fierce Biotech's fifth annual layoff tracker, a resource designed to keep pace with the sector's steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...

Baystreet.ca News Commentary – The global oncology therapeutics market reached $164.2 billion in 2025 and is projected to hit $285.4 billion by 2030[1]; it signaled a massive ...

Both educators hope their awards will shine a light on the importance of ensuring that all students feel welcome and ...

HousingAnywhere reports on 10 top European cities for US students in 2026, blending education, culture, and career ...

Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...

Moore’s widower, S. Robert Levine, MD, launched the nonprofit in his famous wife’s memory to advance research and accelerate ...

Altimmune, Inc. closed a $75 million direct offering to fund Phase 3 pemvidutide trials for MASH. Learn more about ALT stock ...